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Abstract: Alcohol dehydrogenases (ADH) are versatile and useful 
enzymes employed as biocatalysts, especially for the selective 
oxidation of primary and secondary alcohols, and for the reduction of 
carbonyl moieties. A new alcohol dehydrogenase (HeADH-II) has 
been identified from the genome of the halo-adapted bacterium 
Halomonas elongata, which proved stable in the presence of polar 
organic solvents and salt exposure. Unusual for this class of 
enzymes, HeADH-II lacks enantiopreference and is capable of 
oxidizing both alcohols and aldehydes, enabling a direct 
overoxidation of primary alcohols to carboxylic acids. HeADH-II was 
coupled with a NADH-oxidase from Lactobacillus pentosus (LpNOX) 
to increase the process yields and allowing recycling of the cofactor. 
The enzymatic oxidation of primary alcohols was also paired with in 
situ condensation of the intermediate aldehydes with hydroxylamine 
to prepare the corresponding aldoximes, with particular attention to 
perillartine (a powerful sweetener), whose enzymatic synthesis 
starting from natural sources, leads to an equally natural product. 
Analysis of the apo-crystal structure of HeADH-II (4.0 Å), highlighted 
evident active sites similarities with two mammalian ADHs that also 
have overoxidative activities, implying possible shared catalytic 
mechanisms. 
Introduction 
Alcohol dehydrogenases (ADHs) have acquired increasing 
interest as versatile chemo- and enantioselective biocatalysts.[1-
3] While classic ADH-mediated oxidation of alcohols to the 
corresponding carbonyl compounds are well known, [4-6] just a 
few examples of complete (primary) alcohol oxidation to 
carboxylic acids have been reported to date, often involving 
complex cascade enzymatic reactions.[7-9] The identification of 
novel biocatalysts capable of overoxidative activity towards 
primary alcohols under mild conditions is essential for green and 
sustainable chemistry.[8] Classically, the oxidation of primary 
alcohols is chemoselective and leads to the exclusive formation 
of aldehydes. Further oxidation is generally obtained by coupling 
ADHs with an aldehyde dehydrogenase (AldDH) or by using 
whole cell systems, such as acetic acid bacteria. [10,11] However, 
oxidation of aldehydes via ADH has been observed with horse 
liver dehydrogenase (HLADH), which catalyzes the dismutation 
of short-chain aliphatic aldehydes, in the presence of an excess 
of NAD+;[6] the complex HLADH-NAD+ firstly performs the 
oxidation of the aldehyde generating the carboxylic acid, while 
the newly formed complex (HLADH-NADH) binds another 
aldehyde molecule, catalyzing its reduction to alcohol. In this 
fine equilibrium, the hydration of the aldehyde plays an important 
role since the free form is the substrate for reduction, whereas 
the hydrate gem-diol is the actual substrate for oxidation. With 
simple aliphatic aldehydes, which freely interconvert between 
the two forms, an equivalent amount of alcohols and carboxylic 
acids is formed at the end of the process with HLADH, thus 
promoting an enzymatic Cannizzaro reaction.[7] Könst et al. 
screened 70 different ADHs and only 9 showed significant 
accumulation of acid, demonstrating that this activity is rather an 
exception.[9] In particular, a mutant ADH (ADH-9V1), with lower 
binding affinity towards NADH than the wild-type enzyme, was 
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able to better catalyze aldehyde oxidation. The conversion was 
further increased by recycling the cofactor with an H2O-forming 
NAD(P)H-oxidase (NOX) from Lactobacillus sanfranciscensis 
and performing the reaction at pH 9.0 where a higher amount of 
gem-diol is present. Under optimized conditions (21 h), ADH-
9V1 catalyzed the oxidation of primary alcohols into carboxylic 
acids with conversions ranging from 9 to 37% for aromatic 
substrates, and 70-73% for simple aliphatic alcohols.[9]  
New enzymes with improved solvent tolerance may be found 
in extremophiles.[12] ADHs with greater stability towards polar 
organic solvents have been expressed from halophilic 
microorganisms[13] and from amplified genomes from 
unculturable species occurring in brine pool. [14,15] In this work, an 
ADH gene (HeADH-II) identified from the genome of Halomonas 
elongata was codon optimized and expressed in E. coli; 
Halomonas elongata is a halo-adapted bacterium which has 
been previously used as source of enzymes with remarkable 
solvent-tolerance and stability under operating conditions.[16-19] 
HeADH-II was characterized and used as biocatalyst, proving its 
ability to oxidize both primary alcohols and aldehydes, showing 
enhanced stability towards water-miscible co-solvents (e.g., 
DMSO).  
In order to gain insight into the possible structural 
determinants of the overoxidative activities of HeADH-II, the low-
resolution crystal structure of the apo-form of HeADH-II, solved 
at 4.0 Å, is here-presented, revealing a tetrameric quaternary 
arrangement and the canonical monomeric fold of the zinc-
dependent ADHs. Despite the resolution of the data, the 
coordinating residues of the zinc binding sites were visible, 
enabling us to infer structural similarities with other ADH 
enzymes of mammalian origin that also catalyze alcohol 
overoxidations.  
 
Results and Discussion 
 
The activity and stability of HeADH-II were firstly evaluated 
using the reduction of cinnamaldehyde to cinnamyl alcohol as 
standard reaction (See Supporting Information). The highest 
activity of HeADH-II was found at pH 5.0 in a temperature range 
of 45-65 °C. The presence of salts has been well tolerated; the 
utmost activity was surprisingly recorded in the presence of 3 M 
NaCl; remarkably, the addition of DMSO had minor effect on the 
enzyme performance since only 8% of the original activity was 
lost in the presence of 10% (v/v) DMSO, and just 18% with 20% 
(v/v) of the same co-solvent. The highest stability was found at 
25 °C and pH 8.0; high stability was also observed in the 
presence of NaCl and KCl and DMSO (10-20%), confirming the 
possibility of using HeADH-II with water-miscible co-solvents or 
relatively high salt concentrations.  
Reduction of cinnamaldehyde (20 mM) into cinnamyl alcohol, 
with a stoichiometric amount of NADH, was carried out at pH 8.0, 
30 °C (best compromise between activity and stability) in the 
presence of HeADH-II (1 U/mL), showing 65% molar conversion. 
Relatively high concentrations of DMSO (15%) were used to 
better solubilize cinnamaldehyde, which is only slightly soluble in 
water (1.05 g/L, 8 mM at 20 °C).[20] 
The reverse reaction (oxidation of cinnamyl alcohol) was 
performed in the presence of stoichiometric amounts of NAD+ at 
different pHs. Oxidation generally occurred with formation of cin-
namaldehyde and, unexpectedly, cinnamic acid, albeit with low 
conversion of the substrate (Scheme 1). To increase the yields 
of the oxidations, bioconversions were carried out with HeADH-II 
(1 U/mL) in the presence of NAD+ (0.1-10 mM), a NADH-oxidase 
from Lactobacillus pentosus (LpNOX) (10 U/mL) and FAD (0.1 
mM) (Scheme 1).  
Scheme 1. Oxidation of cinnamyl alcohol and cinnamaldehyde with cofactor 
recycling 
 
To combine the two different enzymes in an one-pot reaction, 
the reaction conditions were set so that also LpNOX (employed 
to re-oxidize the cofactor) could optimally perform; LpNOX is 
active between pH 5.0-9.0 and 25-50 °C.[21] Therefore, 
preparative oxidation of both cinnamyl alcohol and 
cinnamaldehyde were firstly carried out at different pHs (5.0-8.0) 
and 30 °C. The reaction leads to the accumulation of aldehyde, 
as also seen in the experiments without cofactor regeneration 
with a maximum conversion around 93-95%, while cinnamic acid 
was produced only in small amounts. The biotransformation did 
not proceed further after the apparent equilibrium was reached 
within one hour, regardless of the medium pH. This behavior 
may be ascribed to the low stability of LpNOX, with subsequent 
interruption of cofactor recycling. To check this hypothesis, fresh 
LpNOX (10 U) was added after each hour, showing that 
oxidation proceeded to carboxylic acid with conversions up to 
99% (See Supporting Information), again independently of the 
pH.  
The oxidative reaction with fed-batch addition of LpNOX was 
then applied to different aromatic alcohols and aldehyde (Table 
1).  
Table 1. Oxidation of different primary alcohols using HeADH-II.  
Reaction conditions:  a) 20 mM substrate in DMSO (15% v/v), 0.1 mM NAD+, 
0.1 mM FAD, HeADH-II (1 U/mL) in Tris-HCl buffer 100 mM, pH 8.0, fed-batch 
addition of LpNOX (10 U) every hour; b) 20 mM substrate in DMSO (15% v/v), 
0.1 mM NAD+, 0.1 mM FAD, HeADH-II (1 U/mL), LpNOX (10 U/mL), in Tris-
HCl buffer 100 mM, pH 8.0 at 30 °C. 
 
The bioconversion of benzyl alcohol derivatives (Entries 2-4, 
Table 1) occurred in a manner similar to what was observed with 
cinnamyl alcohol, with an initial accumulation of aldehyde and 
complete oxidation into carboxylic acids with fed-batch addition 
of LpNOX. For fast-reacting substrates (Entries 5-7, Table 1), 
acid formation was complete in short timescales without further 
 
Entry Substrate  Aldehyde Acid Time (h) 
1 Cinnamyl alcohola - > 98 4 
2 Benzyl alcohola 10 90 16 
3 Piperonyl alcohola 5 95 16 
4 4-Methoxybenzyl alcohola - > 98 8 
5 2-Phenyl-1-ethanolb - > 98 2 
6 3-Phenyl-1-propanolb - > 98 2 
7 (R,S)-2-Phenyl-1-propanolb - > 98 3 
FULL PAPER    
3 
 
addition of LpNOX. Surprisingly, despite the short reaction time, 
no trace of enantioselectivity was observed with racemic 2-
phenyl-1-propanol (Entry 7), which was completely oxidized in 3 
hours obtaining the corresponding acid as racemate. With 
respect to the previous reported methodology, involving a 
mutated ADH with lower affinity for NADH,[9] the new strategy 
allows a 4-fold higher substrate loading (20 mM) while the 
aromatic acids were obtained with greater yields and in shorter 
reaction times.  
To further investigate the substrate scope of this new 
enzyme, secondary alcohols were also tested under the above 
described reaction conditions (Figure 1); no fed-batch addition of 
LpNox was necessary. Virtually all reported ADHs display a 
strong enantiopreference towards either R or S secondary 
alcohols,[22] but while HeADH-II showed activity towards (R,S)-1-
phenyl ethanol (1a, Figure 1, 65% m.c., 2 h) no 
enantiopreference was observed. No conversion was obtained 













Figure 1. Oxidation of secondary alcohols using HeADH-II. Reaction 
conditions: 20 mM substrate in DMSO (15% v/v), 0.1 mM NAD+, 0.1 FAD, 
HeADH-II (1 U/mL), LpNOX (10 U/mL), in Tris-HCl buffer 100 mM, pH 8.0 at 
30 °C. 
 
To confirm the rare characteristic concerning the lack of 
enantioselectivity of the enzyme,  HeADH-II was assayed also in 
the reductive direction with acetophenone (20 mM) and a 
stoichiometric amount of NADH. The corresponding racemic 1-
phenyl ethanol was obtained as product (70% m.c., 6 h) (See 
Supporting information).  
HeADH-II was subsequently employed for the direct 
oxidation of aldehydes into the corre-sponding carboxylic acids 
with high conversion (Table 2). 
 
Table2. Oxidation of different aldehydes using HeADH-II. 
Reaction conditions:  20 mM substrate in DMSO (15% v/v), 0.1 mM NAD+, 0.1 
mM FAD, HeADH-II (1 U/mL), LpNOX (10 U/mL), in Tris-HCl buffer 100 mM, 
pH 8.0 at 30 °C. 
 
Aldehyde oxidation was generally rapid, and no further 
addition of LpNOX was necessary to obtain high yields in short 
reaction times. Transient formation of aldehydes in the two-step 
enzymatic oxidation of primary alcohols at pH 8.0 led us to 
explore the possibility of condensing the intermediate aldehydes 
with hydroxylamine, thus furnishing the corresponding 
aldoximes.[23] In this instance, three different substrates were 
selected (Table 3). 
 
Table3. Oxidation of primary alcohols using HeADH-II in the presence of 
NH2OH. 
 
Reaction conditions:  20 mM substrate in DMSO (15% v/v), NH2OH.HCl (24 
mM), 0.1 mM NAD+, 0.1 mM FAD, HeADH-II (1 U/mL), LpNOX (10 U/mL), in 
Tris-HCl buffer 100 mM, pH 8.0 at 30 °C. 
 
The biotransformations performed in the presence of NH2OH 
allowed the recovery of the aldoximes with conversions >80%. It 
should be noted that aldoximes can be easily converted into 
aldehydes by mild and efficient hydrolysis. Synthesis of 
perillartine from perillyl alcohol (Entry 3, Table 3, Scheme 2) was 
investigated as a molecule of interest in the food industry. It is 
typically employed as non-protein sweetener since it is 2000-fold 
sweeter than sucrose. Perillartine is usually chemically prepared, 
starting from perillaldehyde extracted from plants (e.g., Perilla 
frutescens).[24] Particular attention to the synthesis of this 
compound was promoted by the need to develop natural 
processes for the preparation of food additives: the obtainment 
of perillartine through the enzymatic conversion of a natural 
substrate allows to label and commercialize the corresponding 









Scheme 2. Preparation of perillartine from perillyl alcohol 
 
The 3D structure of apo-HeADH-II 
 
In order to understand the structural arrangement of HeADH-
II that may explain its peculiar overoxidative activities, the crystal 
structure of apo-HeADH-II was solved, as described in the Sup-
porting information section. In agreement with size exclusion 
 
Entry Substrate  Acid (%) Time (h) 
1 Cinnamaldehyde 94 6 
2 Benzaldehyde > 98 8 
3 Piperonal > 98 8 
4 4-Methoxybenzaldehyde > 98 8 
5 Phenylacetaldehyde > 98 2 
6 3-Phenylpropionaldehyde > 98 2 
7 (R,S)-2-Phenylpropanal >99 2 
   
Entry Substrate Aldoxime (%) Time (h) 
1 Cinnamyl alcohol 86 3 
2 Benzyl alcohol 86 6 
3 Perillyl alcohol 82 2 
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chromatography studies (See Supporting Information), HeADH-II 
assembles as a compact tetramer with an estimated assembly 
ΔG of -137.5 kcal/mol, as calculated using PDBePISA [25] 
(https://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver; Figure 
1a). Electron density was present for main chain residues 2 to 
341 (chain A), 4 to 341 (chain B) 6 to 332 (chain C) and 5 to 341 
(chain D). The remaining N- and C-terminal residues and other 
loop regions were absent and lost to the solvent. Despite the low 
resolution of the data, the two zinc binding sites per chain were 
clearly observed (Figure 1b & Supporting Information Figure S8). 
 
Figure 1. The crystal structure of HeADH-II. A) The quaternary arrangement of 
HeADH-II, illustrating the tetramer present in the crystal asymmetric unit; B) 
Secondary structure ribbon representation of the HeADH-II monomer, 
indicating the nucleotide binding domain, the catalytic domain, the N- and C-
termini and bound zinc ions (green spheres). A close-up of the catalytic zinc 
binding site of chain B is shown with the coordinating residues in sticks; C) 
Superposition of chain A of HeADH-III (green) with human liver χχ ADH (grey) 
PDB entry 1TEH).[26] The bound NAD(H) cofactor of human liver χχ ADH is 
shown (sticks) to highlight the coenzyme binding site. This figure was 
prepared using Chimera.[27] 
 
In line with other zinc-dependent ADHs, each apo-HeADH-II 
monomer folds into two sub-domains: a catalytic domain 
composed of a central mixed β-sheet, flanked by two antiparallel 
β-sheets, six α-helices and three 310 helices, and a smaller 
nucleotide-binding domain, which adopts the canonical 
Rossmann fold, typical of NAD(H)-binding proteins, comprising a 
six-stranded parallel β-sheet flanked by six α-helices (Figure 1b). 
A long helical hinge region (residues 144-165) connects the two 
domains, forming a cleft to which the coenzyme binds in other 
ADHs of known structure. Based on apo- and coenzyme bound 
structures, significant conformational changes are proposed to 
occur during the mechanism due to this hinge region, with the 
enzyme alternating be-tween an open, unbound form to a closed, 
coenzyme and substrate-bound form.[28]  
In agreement with our functional data showing that HeADH-II 
efficiently catalyzes the oxidation of cinnamyl alcohol, the DALI 
secondary structure matching server 
(http://ekhidna2.biocenter.helsinki.fi/dali/),[29] revealed the 
cinnamyl ADH (SbCAD4; PDB entry 5VKT) from Sorghum 
bicolor (RMSD 2.1Å over 333/353 aligned  C-alpha atoms; 31% 
sequence identity) as the top structural homolog. [30] The main 
structural differences arise in loop regions and in the catalytic 
domain, and also in the overall quaternary arrangement, with 
SbCAD4, being a dimer.  Both HeADH-II and cinnamyl ADHs 
are zinc-dependent enzymes, however the latter prefers 
NADP(H) to NAD(H) and usually favors aldehyde reduction over 
alcohol oxidation.[30]  
The He-ADH-II active site 
Each HeADH-II chain contains two zinc ions bound at each 
subdomain (Figure 1b). The structural zinc cation bound at the 
catalytic domain is coordinated by interactions with the sulfur 
side chain atoms of four cysteines C96 (2.2 Å), C99 (2.2 Å), 
C102 (2.3 Å) and C110 (2.3 Å) (See Supporting Information 
Figure S8).  The catalytic zinc cation, involved in substrate 
binding, is bound at the nucleotide binding subdomain via 
tetrahedral interactions (bond lengths in parenthesis for chain B) 
with C42(SG) (2.6 Å), C152(SG) (2.7 Å), T44(OG1) (2.1 Å) and 
H67(NE2) (2.6 Å) in chains B to D (Figure 1b). Another residue 
in close vicinity to the zinc binding site is E66, however its side-
chain was not clearly visible at the given resolution. Interestingly, 
the involvement of a glutamate in zinc coordination was 
observed as an atypical feature in human liver χχ ADH (PDB 
entry 1TEH).[26] In agreement with the overoxidative activities of 
HeADH-II, the human enzyme catalyzes substrate oxidation of 
long-chain alcohols, and also S-hydroxymethyl-glutathione.[26] 
Despite having different phylogenetic origins, similarities in 
the active sites of HeADH-II and human liver χχ ADH (E-value: 
4.72E-09) and horse liver alcohol dehydrogenase (PDB entry 
1QLH: E-value: 6.21E-07), which both carry out oxidative 
reactions were underlined by an enzyme template search using 
Profunc (http://www.ebi.ac.uk/thornton-srv/databases/ProFunc/; 
[26,28,31] (See Supporting Information). 
HeADH-II and human liver χχ ADH share a low sequence 
identity of 28.9% (for 304/380 fit-ted residues), and a structural 
identity of 99.7% (Figure 2d). The local sequence identity (41 
equivalenced residues) surrounding the three matched active 
site residues, increases to 48.8% with 20 identical and 8 similar 
neighboring active site residues, reflecting increased 
conservation in this region.  
Direct coordination of E68 (human χχ ADH) has been 
proposed to represent a reaction intermediate that assists in 
product release and the water exchange step during catalysis. 
Accordingly, this glutamate is replaced by a coordinating water 
molecule in chain A of the human χχ ADH. The resolution of our 
data, however, was not sufficient to visualize water molecules. 
The oxidation of long-chain alcohols, accommodated by a 
larger than usual active site in human liver χχ ADH, is suggested 
to occur via a catalytic mechanism similar to that of class I ADH 
that requires a significant decrease in the pKa of the alcohol 
substrate due to direct coordination with the zinc ion. As 
observed upon superposition of the two enzymes, HeADH-II 
also has a comparably large active site (Figure 1c). The catalytic 
mechanism of human liver χχ ADH is proposed to employ H47 
(H67 in HeADH-II) as the catalytic base, with a double role also 
in NAD(H) binding.  During the mechanism, a proton-relay 
pathway is suggested, involving transfer of the substrate’s 
hydroxyl proton, with passage from inside the active site to the 
solvent. In class I ADHs, mutagenesis studies have shown that 
the proton relay is mediated by residues T48 (T44 in HeADH-II), 
the 2'-hydroxyl of the nicotinamide ribose in NAD(H), and the 
imidazole of His47, with the latter acting as the catalytic base in 
the reaction. Given the sequence and structural conservation of 
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analogous residues in HeADH-II, a similar mechanism may be 
implied.   
Concerning horse liver ADH (HLADH), the zinc coordinating 
cysteines and histidine residues were matched (local sequence 
ID 35.7% over 41 equivalenced residues); a coordinating 
glutamate was not observed in the structure of HLADH, although 
the authors predicted its role computationally.[32] The authors 
also predicted the role of S48 (T44 in HeADH-II) in proton 
shuttling.  
In silico modelling and docking studies 
 
To further study the catalytic properties of HeADH-II and 
integrate the information obtained with the apo-crystal structure, 
a model of the holo-form was created with MODELLER,[33] using 
as query the holo-form of the bacterial ADH from Brucella 
melitensis (BmADH, PDB entry 3MEQ) which has over 70% 
sequence identity. To complete the model, the zinc atoms were 
added and the cofactor, NAD+, docked to the structure using 
autodock VINA software.[34] The resulting model, compared to 
the apo crystal structure, was only different in the position of 
three loops close to the active site (See Supporting Information, 
Figure S9).  
As mentioned, ADHs normally exhibit very high 
enantioselectivities, closely related to the shape and size of the 
catalytic cleft which tends to display clearly differentiated small 
and large pockets. Such architecture favours efficient binding of 
just one stereoisomer (in the oxidative direction), and promotes 
the hydride transfer only to one face of the carbonyl molecule (in 
the reductive direction).[35] In contrast, HeADH-II appears to lack 
any enantiopreference with the tested substrates in either 
catalytic direction. Only a few wild-type ADHs have been found 
to have reduced enantiopreference[36,37] while protein 
engineering can lead to a less selective variants. [34,38,39] The 
catalytic cleft of HeADH-II appears to be symmetric, with 
undistinguishable pockets, unlike the majority of ADH structures 
reported (including that of BmADH).[34] To illustrate the 
differences in the catalytic cleft, RCR ((R)-selective carboxyl 
reductase from Candida parapsilosis) and TeSADH (non-
enantioselective secondary alcohol dehydrogenase from 
Thermoanaerobacter ethanolicum) were compared to HeADH-
II.[40,41] Despite a less than 30% of sequence homology (See 
Supporting Information, Figure S10A), the three enzymes exhibit 
a similar folding and a very similar architecture of the active site 
(See Supporting Information, Figure S10B), mainly differing in 
the size of their pockets (Figure 2A). In RCR, the two pockets 
are clearly distinguishable with a small pocket limited by F285 
and W286. Upon mutation to alanine of either of those (F285A 
or W285A), the additional space causes the loss of 
enantioselectivity for (R,S)-2-phenyl-1-propanal.[42] The HeADH-
II quasi symmetric catalytic site displays a I290 and a V291 
which leave enough space in the upper pocket for bulky 
substituent (Figure 2B). In addition, T44 and specially the 
orientation of W91, extend the size of the other pocket, which 
mimics RCR and TeSADH. Both positions have been previously 
probed to investigate the stereoselectivity of HLADH. [38] 
Specifically, the presence of a phenylalanine in the 
corresponding W91 position, oriented towards the catalytic site, 
reduces the size of the pocket (See Supporting information, 
Figure S11). Notably, W91 in HeADH-II appeared to be quite 
static during the short MD simulation, staying parallel to the 
opening of the catalytic cleft, as in TeSADH. 
Docking studies of HeADH-II with both (R)- and (S)-1-
phenylethanol were performed; both enantiomers could be fitted 
in the active site with identical energies, very similar 
conformations, and catalytically plausible orientations (Figure 
2B).   
  
Figure 2. A) Comparison of the catalytic pockets of HeADH-II, TeSADH and 
RCR. The labelled residues which are defining each of the pockets are 
coloured in light cyan or yellow and their surface is shown.  B) Detail of the 
docking of (R)- and (S)- 1-phenylethanol. The S enantiomer is shown in blue 
and the R in green. The docking energies obtained were -5.4 kcal/mol and -5.6 
kcal/mol, respectively. 
Conclusion 
We successfully characterized and applied a promiscuous 
halophilic ADH (HeADH-II) that can oxidize both alcohols and 
aldehydes to the corresponding carboxylic acid. Based on 
observations made between the crystal structure of HeADH-II, it 
shares structural characteristics with mammalian ADHs that also 
carry out oxidative reactions. Such structural similarities and 
common functional activities may imply a shared catalytic 
mechanism. This new enzyme demonstrated great activity and 
stability at high salt and polar solvent concentrations, usually 
employed for solubilizing organic compounds in water media. 
Enzymes derived from extremophiles, such as the halo-adapted 
bacterium Halomonas elongata, are particularly suitable for 
industrial processes thanks to their adaptation to harsher 
reaction environments. HeADH-II showed broad substrate 
specificity: different aromatic primary alcohols and aldehydes 
were fully converted to the final carboxylic acid. Moreover, the 
oxidation of racemic 1-phenylethanol to the corresponding 
ketone was obtained with good conversion, thus demonstrating 
enzyme versatility. Interestingly, no enantiopreference was 
observed. This uncommon characteristic could be explained by 
the symmetry observed in the catalytic pockets of HeADH-II 
which allows both (R)- and (S)-1-phenyl ethanol to fit as a mirror 
images in a catalytically plausible conformation. HeADH-II 
therefore can be included with only a few other examples in the 
list of non-stereoselective ADHs which could offer major ad-
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vantages in hydrogen borrowing cascades for the synthesis of 
chiral amines from the racemic alcohols.[43] 
To further optimize the process, in situ recycling of the 
cofactor was performed by adding a second enzyme (LpNOX) 
that allowed the generation of a self-sustaining enzymatic 
system with the use of catalytic amounts of NAD+. Unfortunately, 
the NADH-oxidase from Lactobacillus pentosus (LpNOX) was 
found to be unstable at prolonged reaction times, so fed-batch 
experiments were carried out to obtain a two-step transformation 
with almost complete conversion.  Further applications 
particularly focused on the enzymatic preparation of perillartine 
(deriving from the condensation of aldehydes with 
hydroxylamine) were performed. This reaction proceeds at room 
temperature and under the atmospheric pressures. Using an 
NAD+ regenerating system, catalytic amount of the cofactor 
could be employed. As the only by-product is water, this system 
can be considered sustainable and applicable for the 




NMR spectra were recorded on a Varian Gemini 300 MHz 
spectrometer using the residual signal of the deuter-ated solvent 
as internal standard. 1H chemical shifts (δ) are expressed in ppm, 
and coupling constants (J) in hertz (Hz). Merck Silica gel 60 
F254 plates were used for analytical TLC; flash column 





All reagents and solvents were obtained from commercial 
suppliers and were used without further purification. 
Cloning, expression and purification 
The synthetic gene encoding for HeADH-II from Halomonas 
elongata, directly cloned into vector pET-28b(+) was purchased 
from BaseClear. The gene, optimized for the expression in E. 
coli, presented an N-terminal his-tag. The resulting pET28b-
HeADH-II was transformed into chemically competent E. coli 
BL21 (DE3) pLYsS for heterologous expression. Plates of E. coli 
BL21 (DE3) pLYsS pET28b-HeADH-II were grown overnight at 
37 °C in LB-agar medium supplemented with 25 μg/mL 
kanamycin and 35 μg/mL chloramphenicol. 200 mL of 
autoinduction  medium: 10 g/L  N-Z amine, 5 g/L yeast extract, 
50 mL KH2PO4  1 M, 50 mL K2HPO4 1 M, 25 mL (NH4)2SO4 1 M, 
2 mL MgSO4 1 M, 2 mL trace element solution (FeSO4 50 mM, 
CaCl2 20 mM, MnCl2 10 mM, ZnSO4 10 Mm, CoCl2 2 mM, CuCl2 
2 mM, NiCl2 2 mM, HCl 60 mM, NaMoO4 2 mM, H3BO3 2 mM), 
20 mL 5052 solution (250 g/L  glycerol, 25 g/L glucose, 100 g/L 
α-lactose), 25 μg/mL kanamycin, 35 μg/mL chloramphenicol) 
were inoculated with a single colony. The cultures were further 
incubated for 16 h at 37 °C, 120 rpm. Cells were then harvested 
by centrifugation (15 min, 5000 rpm, 4 °C), washed once with 
deionized water and stored at -20 °C; 10 g of pellet were 
resuspended in 50 mL loading buffer (Tris-HCl 100 mM pH 8.0, 
imidazole 20 mM, NaCl 100 mM) and sonicated (6 cycles of 2 
min each, in ice, with 1 min interval). Cell debris were harvested 
by centrifugation (45 min, 15000 rpm, 4 °C). Chromatography 
was performed using ÄKTA Purifier (GE Healthcare) with a 1 mL 
column HisTrapTM FF (GE Healthcare) pre-loaded with NiSO4 
(100 mM). Briefly, the column was equilibrated with loading 
buffer and the filtered crude extract loaded; column was then 
washed with loading buffer; finally, the adsorbed enzyme was 
eluted with elution buffer (Tris-HCl 100 mM pH 8.0, imidazole 
250 mM, NaCl 100 mM). 
Crude extract, pellet and pure protein were analyzed by SDS-
PAGE (See Supporting information, Figure S4). The fractions 
showing the presence of a band of the expected size (38 kDa) 
were pooled, dialyzed against Tris-HCl buffer 100 mM, pH 8.0 
and stored at 4 °C. Typically, starting from 10 g of wet cell paste, 
it was possible to obtain 5 mg of pure protein. 
The plasmid pET28a(+) containing the gene encoding for 
LpNOX was kindly provided by Prof. Sieber (University of 
München). The enzyme was expressed and purified as 
previously reported.[44] 
Crude extract, pellet and pure protein were analyzed by SDS-
PAGE (See Supporting information, Figure S5). The fractions 
showing the presence of a band of the expected size (52 kDa) 
were pooled, dialyzed against Tris-HCl buffer 100 mM, pH 8.0 
and stored at 4 °C. Typically, starting from 2 g of wet cell paste, 
it was possible to obtain 10 mg of pure protein. 
HeADH-II activity assays 
Activity measurements were performed spectrophotometrically 
at 340 nm by determining the formation or depletion of NADH at 
25 °C in a half-microcuvette (total volume 1 mL) for 2 min. One 
unit (U) of activity is defined as the amount of enzyme which 
catalyzes the consumption of 1 μmol of NAD+/NADH per minute 
under reference conditions, namely 1 mM NAD+/NADH, 4 mM 
cinnamyl alcohol/cinnamaldehyde, correct amount of HeADH-II 
in Tris-HCl 100 mM, pH 8.0. Specific activity was 3 U/mg and 2.8 
U/mg, respectively. 
LpNOX activity assay 
Activity measurements were performed spectrophotometrically 
at 340 nm by determining the depletion of NADH at 25 °C in a 
half-microcuvette (total volume 1 mL) for 2 min. One unit (U) of 
activity is defined as the amount of enzyme which catalyzes the 
consumption of 1 μmol of NADH per minute under reference 
conditions, namely 1 mM NADH, correct amount of LpNOX in 
Tris-HCl, 100 mM, pH 8.0. Specific activity was 50 U/mg. 
Biotransformations 
Molar conversion and enantioselectivity towards different 
aromatic alcohols and aldehydes were determined by 
performing biotransformations at 20-mg scale, using an enzyme-
coupled system (LpNOX) for cofactor recycling. Oxidations were 
carried out in 10-mL screw-capped test tubes with HeADH-II (1 
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U/mL), LpNOX (10 U/mL), NAD+ (0.1 mM), FAD (0.1 mM), 
substrate (20 mM), DMSO (20% v/v) suspended in Tris-HCl 
buffer 100 mM pH 8.0. To determining conversion of the 
enzymatic reactions 100 µL aliquots were quenched with HCl 
0.1 M at different reaction times and extracted with 100 µL of 
AcOEt for TLC (n-Hexane/AcOEt 9:1). Samples, after 
evaporation, were resuspended in the mobile phase for HPLC 
analysis (See Supporting Information). 
One-pot reaction for the preparation of aldoximes 
One-pot biotransformations were carried out at 20-mg scale 
using 20 mM alcohol as substrate in DMSO (15% v/v), 
NH2OH
.HCl (24 mM), 0.1 mM NAD+, 0.1 mM FAD, HeADH-II (1 
U/mL), LpNOX (10 U/mL), in Tris-HCl buffer 100 mM, pH 8.0 at 
30 °C. 150 µL aliquots were extracted with AcOEt at different 
reaction times and analyzed by gas-chromatography (See 
Supporting Information). 
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An unusual alcohol dehydrogenase has been identified from the halo-adapted bacterium H. elongata. HeADH-II  shows a great 
stability to polar solvents and high salt concentration as well as uncommon characteristics as the lacking of  enantiopreference and 
the capability of overoxidizing alcohols to carboxylic acids. To increase the process yields and allowing the cofactor recycling 
HeADH-II was coupled with a NADH-oxidase from L. pentosus (LpNOX).  
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